The MCL-1 BH3 helix is an exclusive MCL-1 inhibitor and apoptosis sensitizer

Author(s)
Stewart, Michelle L.; Fire, Emiko; Keating, Amy E.; Walensky, Loren D.
Thumbnail
DownloadKeating_The MCL-1.pdf (1.248Mb)
OPEN_ACCESS_POLICY
Terms of use
Creative Commons Attribution-Noncommercial-Share Alike 3.0 http://creativecommons.org/licenses/by-nc-sa/3.0/
Metadata
Show full item record
Abstract
MCL-1 has emerged as a major oncogenic and chemoresistance factor. A screen of stapled peptide helices identified the MCL-1 BH3 domain as selectively inhibiting MCL-1 among the related anti-apoptotic Bcl-2 family members, providing insights into the molecular determinants of binding specificity and a new approach for sensitizing cancer cells to apoptosis.
Description
available in PMC 2011 February 3.
Date issued
2010-08
URI
http://hdl.handle.net/1721.1/73960
Department
Massachusetts Institute of Technology. Department of Biology
Journal
Nature Chemical Biology
Publisher
Nature Publishing Group
Citation
Stewart, Michelle L et al. “The MCL-1 BH3 Helix Is an Exclusive MCL-1 Inhibitor and Apoptosis Sensitizer.” Nature Chemical Biology 6.8 (2010): 595–601. Web.
Version: Author's final manuscript
ISSN
1552-4450
1552-4469
Collections